Post-diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study.
Ming-Ming HeKai WangChun-Han LoYiwen ZhangGeorgios PolychronidisMarkus D KnudsenRong ZhongYuan MaKana WuAndrew T ChanEdward L GiovannucciShuji OginoKimmie NgJeffrey A MeyerhardtMingyang SongPublished in: Cancer (2024)
Use of multivitamin supplements at a moderate dose after a diagnosis of nonmetastatic CRC is associated with lower CRC-specific and overall mortality, whereas a high dose (≥10 tablets/week) use is associated with higher CRC-specific mortality.